Impact of Insurance Status on Clinical Management and Outcomes of Patients with ST-Segment Elevation Myocardial

Sayed Abdulmotaleb Almoosawy1, Abdullah Esmaiel2, Ibrahim Farrag2

  • 1Department of Internal Medicine, Al-Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.

Insights

Insurance status did not impact ST-segment elevation myocardial infarction (STEMI) patient outcomes in Kuwait. Free essential services ensured similar in-hospital and 30-day mortality and adverse events for both insured and noninsured STEMI patients.

Area of Science:

  • Cardiology
  • Health Services Research
  • Public Health

Background:

  • Discrepancies in clinical management and outcomes for ST-segment elevation myocardial infarction (STEMI) patients based on health-care insurance type are emerging globally.
  • The Kuwait government offers free essential treatments for specific emergency conditions, including to uninsured patients.
  • This study investigated potential disparities in STEMI patient care and outcomes related to insurance status within Kuwait.

Purpose of the Study:

  • To compare clinical management and in-hospital and 30-day outcomes for STEMI patients with different insurance types in Kuwait.
  • To assess the impact of insurance status on acute and short-term adverse cardiac events in STEMI patients.
  • To evaluate the effectiveness of government-provided free essential services for uninsured STEMI patients.

Main Methods:

  • Data were sourced from the Kuwait Catheterization Laboratory Project (Kuwait CLAP) registry.
  • Adult STEMI patients (≥18 years) enrolled between February 2020 and February 2021 were categorized as insured or noninsured.
  • Coprimary outcomes included in-hospital and 30-day mortality, with comparisons of adverse cardiac events.

Main Results:

  • Out of 668 STEMI patients, 116 (17%) were insured and 552 (83%) were noninsured.
  • In-hospital mortality was 2.6% for insured and 1.6% for noninsured; 30-day mortality was 0% for insured and 0.7% for noninsured, with no significant differences (P=0.447 and P=1, respectively).
  • Rates of in-hospital complications and 30-day adverse events were similar between insured and noninsured groups.

Conclusions:

  • No significant differences in acute or short-term outcomes were observed between STEMI patients with different insurance statuses in Kuwait.
  • These findings are reassuring, indicating that free essential services provided by the Kuwait government do not compromise outcomes for uninsured STEMI patients.
  • The study supports equitable care delivery for STEMI patients regardless of insurance status in the Kuwaiti healthcare system.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
1
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
1
Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
1
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
1
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
1
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K